Abstract:Background: Brachial plexus magnetic resonance imaging (MRI) is an important noninvasive supplementary diagnostic method of chronic immune peripheral neuropathies, but few MRI studies on the preganglionic nerves have been conducted. This retrospective cross-sectional study aimed to establish a reliable assessment for brachial plexus preganglionic nerve thickness and to use this method to assess and compare nerve characteristics in various types of peripheral neuropathies.Methods: Hospitalized patients diagnosed as positive for anti-neurofascin-155 (NF155)-positive autoimmune nodopathy (AN) (NF155+), chronic inflammatory demyelinating polyneuropathy (CIDP), or multifocal motor neuropathy (MMN) at Huashan Hospital of Fudan University in Shanghai, China, who underwent brachial plexus MRI between October 2011 and August 2023 were consecutively recruited for this study. We also recruited participants who underwent brachial plexus MRI during this period with no history of trauma, inflammation, tumors, compression, or degenerative conditions as healthy controls. According to our self-developed semiquantitative assessment of preganglionic nerves, we assessed the bilateral preganglionic C5-C8 nerves individually and scored the enlargement degree from 0 to 4 points. Furthermore, a sum score ≥20 was defined as definite enlargement.Results: A total of 122 participants were enrolled, including 28 with NF155+, 40 with CIDP, 15 with MMN, and 39 healthy controls. In the comparison of the single-nerve scores, we found that there was a significant difference distribution among the four groups (χ2 test; P<0.001), with the patients with NF155+ exhibiting the highest scores in each of the bilateral C5-C8 nerves. In the comparison of the sum scores, a descending tendency was observed in patients NF155+, CIDP, and MMN, with median scores of 11, 4, and 0 points, respectively (Kruskal-Wallis test; P=0.003, P<0.001, and P=0.005, respectively for NF155+ vs. CIDP, NF155+ vs. MMN, and CIDP vs. MMN). The proportion of definite enlargement in those with NF155+ was greater than that in healthy controls (21% vs. 0%; χ2 test; P=0.004), and the sum score at 0 points was lower in the NF155+ group than in CIDP, MMN, and healthy control groups (7% vs. 37%, 87%, and 41%, respectively; χ2 test; P<0.001).Conclusions: This semiquantitative assessment can be a valuable tool for measuring preganglionic nerve enlargement, which was found to be decreased, respectively, in those with NF155+, CIDP, and MMN. Presence of definite enlargement could be a strong indicator of NF155+ in clinic.

Identi¢cation of a 35kDa protein in rat spinal ganglia and sensory ¢bers

Identification of A 35 Kda Protein in Rat Spinal Ganglia and Sensory Fibers

Assay of Serum Antibody to Annexin Ⅴ in Patients with Peripheral Neuropathy

Proteomic Identification of an Upregulated Isoform of Annexin A3 in the Spinal Cords of Rats in a Neuropathic Pain Model.

Purification of a Sensory-Specific Protein of 35Kda(ssp-35).

Secondary Structure and Neurotrophic Effect of a 33.1 kDa Specific Protein (SSP-33.1) in Spinal Sensory Ganglia

Identification of peripheral nerve functional fascicles in Sprague-Dawley rats by the carbon quantum dot-Annexin V antibody complex

EXTRACTION AND IDENTIFICATION OF THE PROTIEN BAND OF 220 000 IN NERVE REGENERATION CONDITIONED FLUID

Purification and Stability Observation of Sensory Nerve-Specific Protein in Rabbit.

Blood Serum Profiling of the Rat Spinal Nerve Ligation Model Using Ultra-Performance Liquid Chromatography-Quadrupole Time-of-flight Mass Spectrometry.

Differential Protein Expression between the Motor and Sensory Fascicles in Rat Femoral Nerve Injury

IMMUNOHISTOCHEMICAL STUDY OF GDNFR-α ON THE NEURONS OF SPINAL CORD AND DRG OF RAT in Vitro

IDENTIFICATION OF PROTEINS IN FLUID COLLECTED FROM NERVE REGENERATION CHAMBERS

Dissociation of Axo-Glial Junction in Anti-Neurofascin 155 Chronic Inflammatory Demyelinating Polyneuropathy.

Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy

Identification and Characterization of a Rat Novel Gene RSEP4 Expressed Specifically in Central Nervous System.

Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy

Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies

Proteomic analysis of spinal cord tissue in a rat model of cancer-induced bone pain

The Preparation and Expression of Neurotrophic Factor in the S ciatic Nerve of Rat

Semiquantitative assessment of preganglionic nerves for chronic immune-mediated neuropathies using brachial plexus magnetic resonance imaging